Strategic Partnership c-LEcta is part of the Kerry Group since 2022 and operates the Kerry Biotechnology Centre, highlighting a strong platform for collaborative enzyme discovery, strain engineering, and scalable production to accelerate joint go-to-market programs.

Expansion & Capacity With the Kerry acquisition and a dedicated biotechnology centre housing 80+ scientists, there is significant capacity for co-development, pilot- to commercial-scale projects, and faster time-to-market for enzyme solutions in food, feed, beverage, and pharma.

Quality & Compliance An ISO 9001 certified quality management system since 2011 demonstrates a mature, compliant operation suitable for regulated markets, reducing risk for customers in food and pharma sectors seeking reliable bio-based solutions.

Global Reach As a global biotechnology company with production and distribution capabilities, c-LEcta offers international access and scalability for customers seeking consistent enzyme products across regions.

Strategic Fit Existing partnerships with Symrise and a broad enzyme engineering and bioprocess portfolio position c-LEcta as a potential vendor or co-developer for customers pursuing next-generation biotechnological solutions in food, beverage, feed, and pharma.